Abstract
• The dual regimen in pediatric living donor liver transplantation had comparable acute cellular rejection rates with triple regimen. • The dual regimen group had higher ebstein-barr virus reactivation rates than in triple regimen group. • Side effects of calcineurin inhibitors were comparable in both regimens. • Discontinuation of antimetabolite drug was more than two-thirds of patients in triple regimen group.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
